Baidu
map

2016 NICE指南:非霍奇金淋巴瘤的诊断和管理(NG.52)

2016-07-20 NICE官网

2016年7月,英国国家卫生与临床优化研究所 (NICE)发布了非霍奇金淋巴瘤的诊断和管理指南,该指南涵盖了大于等于16岁非霍奇金淋巴瘤患者的诊断和管理,目的是通过推进最佳诊断和分期测试以及6种亚型的的最佳治疗方法进而改善该类患者的护理,检测和治疗部分包括切除活检,放射治疗,免疫治疗和干细胞移植。

中文标题:

2016 NICE指南:非霍奇金淋巴瘤的诊断和管理(NG.52)

英文标题:

NICE guidelines [NG52]:Non-Hodgkin’s lymphoma: diagnosis and management

发布机构:

发布日期:

2016-07-20

简要介绍:

2016年7月,英国国家卫生与临床优化研究所(NICE)发布了非霍奇金淋巴瘤的诊断和管理指南,该指南涵盖了大于等于16岁非霍奇金淋巴瘤患者的诊断和管理,目的是通过推进最佳诊断和分期测试以及6种亚型的的最佳治疗方法进而改善该类患者的护理,检测和治疗部分包括切除活检,放射治疗,免疫治疗和干细胞移植。

相关资料下载:
[AttachmentFileName(sort=100, fileName=2016 NICE指南:非霍奇金淋巴瘤的诊断和管理(NG.52))] GetToolGuiderByIdResponse(projectId=1, id=222481c0012a2370, title=2016 NICE指南:非霍奇金淋巴瘤的诊断和管理(NG.52), enTitle=NICE guidelines [NG52]:Non-Hodgkin’s lymphoma: diagnosis and management, guiderFrom=NICE官网, authorId=null, author=, summary=2016年7月,英国国家卫生与临床优化研究所 (NICE)发布了非霍奇金淋巴瘤的诊断和管理指南,该指南涵盖了大于等于16岁非霍奇金淋巴瘤患者的诊断和管理,目的是通过推进最佳诊断和分期测试以及6种亚型的的最佳治疗方法进而改善该类患者的护理,检测和治疗部分包括切除活检,放射治疗,免疫治疗和干细胞移植。 , cover=, journalId=null, articlesId=null, associationId=null, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Wed Jul 20 00:00:00 CST 2016, originalUrl=, linkOutUrl=, content=<div>2016年7月,英国国家卫生与临床优化研究所(NICE)发布了非霍奇金淋巴瘤的诊断和管理指南,该指南涵盖了大于等于16岁非霍奇金淋巴瘤患者的诊断和管理,目的是通过推进最佳诊断和分期测试以及6种亚型的的最佳治疗方法进而改善该类患者的护理,检测和治疗部分包括切除活检,放射治疗,免疫治疗和干细胞移植。 <div><br> 拓展指南:<strong>与<font color=red>非霍奇金淋巴瘤</font>相关指南:</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=222481c0012a2370" title="2016 NICE指南:非霍奇金淋巴瘤的诊断和管理(NG.52)" target=_blank>2016 NICE指南:非霍奇金淋巴瘤的诊断和管理(NG.52)</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=ee4cf1c0011511fa" title="NCCN临床实践指南:非霍奇金淋巴瘤(2015.V2)" target=_blank>NCCN临床实践指南:非霍奇金淋巴瘤(2015.V2)</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=d87191c001138528" title="NCCN临床实践指南:非霍奇金淋巴瘤(2015.V1)" target=_blank>NCCN临床实践指南:非霍奇金淋巴瘤(2015.V1)</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=7c3261c001122274" title="NCCN临床实践指南:非霍奇金淋巴瘤(2014.V5)" target=_blank>NCCN临床实践指南:非霍奇金淋巴瘤(2014.V5)</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=8aed71c001109027" title="NCCN临床实践指南:非霍奇金淋巴瘤(2014.V4)" target=_blank>NCCN临床实践指南:非霍奇金淋巴瘤(2014.V4)</a></li> 更多信息请点击:<a href="//m.capotfarm.com/guideline/list.do?q=%E9%9D%9E%E9%9C%8D%E5%A5%87%E9%87%91%E6%B7%8B%E5%B7%B4%E7%98%A4" target=_blank>有关非霍奇金淋巴瘤更多指南</a></ul></div></div>, tagList=[TagDto(tagId=1170, tagName=非霍奇金淋巴瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=2, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3724, appHits=177, showAppHits=0, pcHits=2250, showPcHits=1785, likes=171, shares=4, comments=4, approvalStatus=1, publishedTime=Mon Jul 25 09:21:11 CST 2016, publishedTimeString=2016-07-20, pcVisible=1, appVisible=1, editorId=5295957, editor=lili, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=lili, createdTime=Mon Jul 25 09:21:11 CST 2016, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 12:07:37 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2016 NICE指南:非霍奇金淋巴瘤的诊断和管理(NG.52))])
2016 NICE指南:非霍奇金淋巴瘤的诊断和管理(NG.52)
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=105266, encodeId=cf43105266ac, content=先下手为强?,学习学习,参考相关知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Sat Aug 27 05:41:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99994, encodeId=355f99994b0, content=值得收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 20:09:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99992, encodeId=b66499992af, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 20:08:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99993, encodeId=2c5299993bb, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 20:08:00 CST 2016, time=2016-08-17, status=1, ipAttribution=)]
    2016-08-27 zibozhouping

    先下手为强?,学习学习,参考相关知识

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=105266, encodeId=cf43105266ac, content=先下手为强?,学习学习,参考相关知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Sat Aug 27 05:41:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99994, encodeId=355f99994b0, content=值得收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 20:09:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99992, encodeId=b66499992af, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 20:08:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99993, encodeId=2c5299993bb, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 20:08:00 CST 2016, time=2016-08-17, status=1, ipAttribution=)]
    2016-08-17 doctorJiangchao

    值得收藏

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=105266, encodeId=cf43105266ac, content=先下手为强?,学习学习,参考相关知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Sat Aug 27 05:41:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99994, encodeId=355f99994b0, content=值得收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 20:09:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99992, encodeId=b66499992af, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 20:08:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99993, encodeId=2c5299993bb, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 20:08:00 CST 2016, time=2016-08-17, status=1, ipAttribution=)]
    2016-08-17 doctorJiangchao

    继续学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=105266, encodeId=cf43105266ac, content=先下手为强?,学习学习,参考相关知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160601/IMG574E13FEE55F33222.jpg, createdBy=929c1478678, createdName=zibozhouping, createdTime=Sat Aug 27 05:41:00 CST 2016, time=2016-08-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99994, encodeId=355f99994b0, content=值得收藏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 20:09:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99992, encodeId=b66499992af, content=继续学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=87, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 20:08:00 CST 2016, time=2016-08-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=99993, encodeId=2c5299993bb, content=继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/jW482SpianMayicTRbRZ5RzfPkmqRTH5rHib5mcib8Wb3QdXjhfOK1UubQL2lictjJFdFJ6Lc3cnnCOSWqxXZ4Kk6y5GdzDoy764R/0, createdBy=156e1644785, createdName=doctorJiangchao, createdTime=Wed Aug 17 20:08:00 CST 2016, time=2016-08-17, status=1, ipAttribution=)]
    2016-08-17 doctorJiangchao

    继续关注

    0

Baidu
map
Baidu
map
Baidu
map